Skip to main content
Eosinophilic Disease
resource center
Menu
Menu
Main navigation
Home
Featured Diseases & Conditions
COVID-19
Depression Care 360
HIV Management
HIV Prevention
Pediatric Influenza
Psoriatic Arthritis
Resources
AbbVie Partner Spotlight
Commentary
Disease State Directory
FDA Alerts
News
Pearls
Podcasts
Polls
Q&As
Quizzes
Slideshows
Videos
Events & Education
Consultant360's Practical Updates in Primary Care
CME
Publication
About Consultant
Consultant Current Issue
Consultant Early View
Consultant Archive
Author Guidelines
Advertising With Consultant360
Search
Login
Menu
Menu
Main navigation
Home
Featured Diseases & Conditions
COVID-19
Depression Care 360
HIV Management
HIV Prevention
Pediatric Influenza
Psoriatic Arthritis
Resources
AbbVie Partner Spotlight
Commentary
Disease State Directory
FDA Alerts
News
Pearls
Podcasts
Polls
Q&As
Quizzes
Slideshows
Videos
Events & Education
Consultant360's Practical Updates in Primary Care
CME
Publication
About Consultant
Consultant Current Issue
Consultant Early View
Consultant Archive
Author Guidelines
Advertising With Consultant360
Eosinophilic Disease
Resource Center
News
News
Resources
Clinical Update
FDA Alerts
Pearls of Wisdom
From the Journal
Insights
Commentary
Podcasts
Q&As
Videos
Interactive
Polls
Quizzes
Slideshows
FDA Alerts
treatment
treatment
FDA Approves First EoE Treatment
05/28/2022
05/28/2022
asthma
asthma
FDA Approves New Option for Severe Eosinophilic Asthma
11/15/2017
The FDA has approved a new add-on maintenance treatment option for patients with severe asthma with eosinophilic phenotype.
11/15/2017
